This document provides guidance on the clinical evaluation of medicinal products in geriatric populations. It gives special consideration to the differences in pharmacokinetic, pharmacodynamic and dose response studies in elderly patients. It also covers drug drug interaction studies. Read together with questions and answers.

Keywords: Older people, geriatrics, elderly, clinical trials

Current effective version

How useful do you find this page?